Use of two in vitro glomerular models to study the renal vasoreactivity of cyclosporine.
L'Azou
B
B
Groupe d'Etude de Physiologie et Physiopathologie Rénales, Faculté de Pharmacie, Bordeaux, France.
Lakhdar
B
B
Cambar
J
J
D000704:Analysis of Variance; D000818:Animals; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D002478:Cells, Cultured; D016572:Cyclosporine / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D015736:Felodipine / Q000494:pharmacology; D005920:Glomerular Mesangium / Q000187:drug effects / Q000502:physiology*; D066298:In Vitro Techniques; D007672:Kidney Cortex / Q000098:blood supply / Q000187:drug effects / Q000502:physiology*; D007678:Kidney Glomerulus / Q000098:blood supply / Q000187:drug effects / Q000502:physiology*; D007700:Kinetics; D009543:Nifedipine / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013997:Time Factors; D014661:Vasoconstriction / Q000187:drug effects*; D014700:Verapamil / Q000494:pharmacology
D002121:Calcium Channel Blockers; D016572:Cyclosporine; D014700:Verapamil; D009543:Nifedipine; D015736:Felodipine